317 related articles for article (PubMed ID: 18598093)
1. Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study.
Sekar V; Lefebvre E; De Marez T; De Pauw M; De Paepe E; Vangeneugden T; Hoetelmans RM
Clin Drug Investig; 2008; 28(8):479-85. PubMed ID: 18598093
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers.
Spence R; Mandagere A; Dufton C; Venitz J
J Clin Pharmacol; 2008 Dec; 48(12):1451-9. PubMed ID: 18832294
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.
Muirhead GJ; Wulff MB; Fielding A; Kleinermans D; Buss N
Br J Clin Pharmacol; 2000 Aug; 50(2):99-107. PubMed ID: 10930961
[TBL] [Abstract][Full Text] [Related]
4. Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.
Sidharta PN; van Giersbergen PL; Wolzt M; Dingemanse J
Br J Clin Pharmacol; 2014 Nov; 78(5):1035-42. PubMed ID: 24962473
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.
Schöller-Gyüre M; Kakuda TN; Sekar V; Woodfall B; De Smedt G; Lefebvre E; Peeters M; Hoetelmans RM
Antivir Ther; 2007; 12(5):789-96. PubMed ID: 17713162
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioequivalence of sildenafil granules and sildenafil tablets in Korean healthy volunteers.
Zheng R; Kim BH
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):530-6. PubMed ID: 24786017
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.
Sekar V; Lavreys L; Van de Casteele T; Berckmans C; Spinosa-Guzman S; Vangeneugden T; De Pauw M; Hoetelmans R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4440-5. PubMed ID: 20660678
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
[TBL] [Abstract][Full Text] [Related]
9. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
Muirhead GJ; Faulkner S; Harness JA; Taubel J
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):37S-43S. PubMed ID: 11879258
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants.
Moore K; Thakkar N; Magee M; Sevinsky H; Vakkalagadda B; Lubin S; Llamoso C; Ackerman P
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0225121. PubMed ID: 35315687
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.
Sekar V; Lefebvre E; Mariën K; De Pauw M; Vangeneugden T; Pozniak A; Hoetelmans RM
Br J Clin Pharmacol; 2009 Jul; 68(1):116-9. PubMed ID: 19660009
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of an orally disintegrating film formulation with a film-coated tablet formulation of sildenafil in healthy Korean subjects: a randomized, open-label, single-dose, 2-period crossover study.
Roh H; Son H; Lee D; Yeon KJ; Kim HS; Kim H; Park K
Clin Ther; 2013 Mar; 35(3):205-14. PubMed ID: 23497759
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
Nichols DJ; Muirhead GJ; Harness JA
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):5S-12S. PubMed ID: 11879254
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
Aberg JA; Tebas P; Overton ET; Gupta SK; Sax PE; Landay A; Falcon R; Ryan R; De La Rosa G
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1184-95. PubMed ID: 22352336
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patients.
Martínez-Rebollar M; Muñoz A; Pérez I; Hidalgo S; Brunet M; Laguno M; González A; Calvo M; Loncà M; Blanco JL; Martínez E; Gatell JM; Mallolas J
Ther Drug Monit; 2013 Aug; 35(4):552-6. PubMed ID: 23851911
[TBL] [Abstract][Full Text] [Related]
17. The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers.
Al-Ghazawi MA; Tutunji MS; AbuRuz SM
Eur J Clin Pharmacol; 2010 Feb; 66(2):159-63. PubMed ID: 19830413
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new orally soluble film formulation of sildenafil administered without water.
Kim EY; Lee SY; Jeon JY; Im YJ; Kim Y; Kim HI; Shin KS; Park SJ; Seo YH; Lee JY; Park JK; Chae SW; Kim MG
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):437-45. PubMed ID: 24786013
[TBL] [Abstract][Full Text] [Related]
19. Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.
Merry C; Barry MG; Ryan M; Tjia JF; Hennessy M; Eagling VA; Mulcahy F; Back DJ
AIDS; 1999 Oct; 13(15):F101-7. PubMed ID: 10546851
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers.
Sekar V; Lefebvre E; De Marez T; De Pauw M; De Paepe E; Vangeneugden T; Hoetelmans RM
Intervirology; 2010; 53(3):176-82. PubMed ID: 20197684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
